Luke E. Esau
Impact in
- Biotechnology top 10%
- Marine Sponges and Natural Products
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Marine Sponges and Natural Products 4
-
- NF-κB Signaling Pathways 1
- Co-authors
- Mandeep Kaur (9 shared papers)Sunil Sagar (8 shared papers)Vladimir B. Bajić (5 shared papers)Basem Moosa (2 shared papers)Niveen M. Khashab (2 shared papers)Fouad Lemtiri‐Chlieh (1 shared paper)Aloysius Wong (1 shared paper)Amanda Ooi (1 shared paper)
- Journals
- BMC Complementary and Alternative Medicine (3 papers)Frontiers in Physiology (1 paper)Nature Communications (1 paper)BioTechniques (1 paper)Science Advances (1 paper)
- Partner nations
- Saudi ArabiaSouth AfricaUnited States
In The Last Decade
Luke E. Esau
17 papers receiving 527 citations
Peers
Comparison fields: 5 of 73
- Biotechnology 29
- Toxicology 20
- Infectious Diseases 63
- Pharmacology 42
- Cancer Research 37
Countries citing papers authored by Luke E. Esau
This map shows the geographic impact of Luke E. Esau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke E. Esau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke E. Esau more than expected).
Fields of papers citing papers by Luke E. Esau
This network shows the impact of papers produced by Luke E. Esau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke E. Esau. The network helps show where Luke E. Esau may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke E. Esau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 66 | |
| 2 | 2016 | 60 | |
| 3 | 2012 | 57 | |
| 4 | 2022 | 52 | |
| 5 | 2009 | 46 | |
| 6 | 2013 | 39 | |
| 7 | 2013 | 38 | |
| 8 | 2023 | 32 | |
| 9 | 2015 | 29 | |
| 10 | 2016 | 25 | |
| 11 | 2008 | 22 | |
| 12 | 2023 | 17 | |
| 13 | 2022 | 16 | |
| 14 | 2023 | 16 | |
| 15 | 2015 | 10 | |
| 16 | 2016 | 9 | |
| 17 | 2019 | 6 |
About Luke E. Esau
Luke E. Esau is a scholar working on Biotechnology, Cancer Research, Pharmacology, Infectious Diseases and Toxicology, having authored 17 papers that have together received 540 indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (4 papers), Microbial Natural Products and Biosynthesis (3 papers), Cell death mechanisms and regulation (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), COVID-19 Clinical Research Studies (1 paper), Click Chemistry and Applications (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Biotechnology (29 citations), Toxicology (20 citations), Infectious Diseases (63 citations), Pharmacology (42 citations) and Cancer Research (37 citations). Luke E. Esau has collaborated with scholars based in Saudi Arabia, South Africa and United States. Frequent co-authors include Mandeep Kaur, Sunil Sagar, Vladimir B. Bajić, Basem Moosa, Niveen M. Khashab, Fouad Lemtiri‐Chlieh, Aloysius Wong, Amanda Ooi, Chris Gehring and Vipan Kumar. Their work appears in journals such as BMC Complementary and Alternative Medicine, Frontiers in Physiology, Nature Communications, BioTechniques and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.